NSE: ALKEM · 30 September 2026 · Dated market coverage
- The stock is -1.65% at ₹5,163.50.
- Likely reason:Sector-led pullback aligned with broader pharma weakness
- Approximate traded value is₹73.73 crore.
- It is -12.98% from its 52-week high and +2.23% from its 52-week low.
- The stock is being compared withNifty Pharmaalongside the Nifty 50.
Why Is Alkem Laboratories Share Price Falling 1.65% Today?
Latest NSE EOD report: 2026-09-29. Today’s Volume: 142,787; 5-Day Avg. Volume: 137,380; 20-Day Avg. Volume: 144,398; Volume vs 20-Day Avg.: 0.99x; Delivery Quantity: 126,663; Delivery %: 51.82%; Number of Trades: 36,626.
Alkem Laboratories (ALKEM) traded lower on September 30, 2026, dropping 1.65% to close at ₹5,163.50. The stock opened at ₹5,245.00, touched a day’s high of ₹5,276.00, and slipped to an intraday low of ₹5,135.00. Trading volume came in at 142,787 shares, remaining closely aligned with its 5-day and 20-day averages, indicating measured participation rather than panic selling.
The broader market and pharmaceutical segment experienced downward pressure during the session. The Nifty index declined 0.42%, while the Nifty Pharma sector index fell more sharply by 1.84%, reflecting broader weakness across healthcare stocks. Alkem’s pullback is largely consistent with this prevailing sector-wide corrective trend rather than an isolated shock.
Company developments over the preceding weeks included product rollouts such as the launch of NeuCeno for partial-onset seizures and Renocia Exo hair growth serum, alongside management changes including the resignation of its Chief Financial Officer. However, these announcements served as background context rather than immediate, direct catalysts for today’s intraday price correction.
medium confidence
- Nifty Pharma sector dropped 1.84% during the session.
- Volume remained in line with short-term averages, showing normal liquidity without aggressive dumping.
Ownership & Transaction Activity
An NSE promoter pledge/encumbrance filing was identified, but the available filing text could not be reduced reliably to a concise current pledge figure.
Source: NSE corporate filing
- Promoters declared no encumbrance on shares for the financial year 2025-26 under SEBI Takeover Regulations.
- Large block deals in June 2026 saw entities such as Jayanti Sinha and Samprada & Nanhamati Singh Family Trust divest stakes, while institutional buyers like ICICI Prudential Mutual Fund and HDFC Mutual Fund absorbed shares.
Source: NSE corporate disclosure. Only factual ownership/shareholding details extracted from the filing are shown.
Research & Brokerage Views
Brokerage views are third-party opinions and are not WittyTrades recommendations.
Historical Bulk / Block Deals
| Type | Date | Party | Side | Qty | Price | Value |
|---|---|---|---|---|---|---|
| Block | 02 Jun, 2026 | JAYANTI SINHA | Sell | 12,38,220 | 5,200 | ₹643.87 Cr |
| Block | 02 Jun, 2026 | ICICI PRUDENTIAL MUTUAL FUND | Buy | 9,03,527 | 5,200 | ₹469.83 Cr |
| Block | 02 Jun, 2026 | SAMPRADA&NANHAMATI SINGH FAMILY TRUST | Sell | 5,50,000 | 5,200 | ₹286.00 Cr |
| Block | 02 Jun, 2026 | HDFC MUTUAL FUND | Buy | 5,09,615 | 5,200 | ₹265.00 Cr |
| Block | 02 Jun, 2026 | DSP MUTUAL FUND | Buy | 86,538 | 5,200 | ₹45.00 Cr |
| Block | 02 Jun, 2026 | SOCIETE GENERALE | Buy | 48,090 | 5,200 | ₹25.01 Cr |
Interpretation:Large institutional transactions can affect liquidity and short-term price behaviour, but should not be read on their own as a directional signal.
WittyTrades Data Insight
Price Position:The stock is around the middle of the day’s trading range.
Move From Open:-1.55%.
Intraday Range:2.69% of the previous close.
5-Day Performance:-4.69%; 20-Day Performance:-0.89%.
Latest Company Developments
What Should Traders and Investors Watch Next?
- Sustained delivery volumes relative to the 51.8% delivery rate observed recently
- Execution progress and doctor feedback on newly launched specialty products like NeuCeno
- Announcements regarding a successor for the outgoing Chief Financial Officer
Catalyst note:No single confirmed company-specific news event drove today’s decline; the move reflects broader pharmaceutical sector weakness.
Frequently Asked Questions
What is the likely reason for today’s move?
Alkem’s 1.65% decline mirrors the broader Nifty Pharma sector downturn of 1.84%. In the absence of adverse company-specific disclosures today, the price movement is best attributed to prevailing sectoral headwinds.
Is trading volume elevated?
Today’s volume is 142,787. The latest 20-day average available is 144,398, equivalent to about 0.99x of the recent average.
Before acting on this stock
Consult your own investment adviser before acting on any security. If you are interested in stock research or other available research categories, review theWittyTrades subscription plans and research segments.
Article by:WittyTrades Research Desk